Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Treasury Shares (2014 - 2024)

Innoviva's (INVA) quarterly Treasury Shares came in at $393.8 million in Q1 2024, little changed YoY from $393.8 million in Q2 2023, and little changed on a QoQ basis from $393.8 million in Q4 2023.

Analysis

Innoviva (INVA) Treasury Shares (2014 - 2024) Analysis & Trends

Innoviva (INVA) has 9 years of Treasury Shares data on file, last reported at $393.8 million in Q1 2024.

  • Quarterly Treasury Shares changed 0.0% year-over-year to $393.8 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $393.8 million (changed 0.0% YoY) and the FY2023 annual result came in at $393.8 million, changed 0.0% from the prior year.
  • Treasury Shares steadied at $393.8 million in Q1 2024, from $393.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $32.0 million in Q2 2021 to a low of $32.0 million in Q2 2021.
  • A 4-year average of $32.0 million and a median of $32.0 million in 2021 frame the typical range for Treasury Shares.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2022, down 0.0% in 2022.
  • Tracing INVA's Treasury Shares over 4 years: stood at $393.8 million in 2021, then changed by 0.0% to $393.8 million in 2022, then changed by 0.0% to $393.8 million in 2023, then changed by 0.0% to $393.8 million in 2024.
  • The last three Treasury Shares figures came in at $393.8 million (Q1 2024), $393.8 million (Q4 2023), and $393.8 million (Q3 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 32.01 Mn
Mar 31, 2024 393.83 Mn
Mar 31, 2024 393.83 Mn
Mar 31, 2024 32.01 Mn
Dec 31, 2023 32.01 Mn
Dec 31, 2023 393.83 Mn
Dec 31, 2023 393.83 Mn
Dec 31, 2023 32.01 Mn
Sep 30, 2023 393.83 Mn
Sep 30, 2023 32.01 Mn
Sep 30, 2023 32.01 Mn
Sep 30, 2023 393.83 Mn
Jun 30, 2023 393.83 Mn
Jun 30, 2023 393.83 Mn
Jun 30, 2023 32.01 Mn
Jun 30, 2023 32.01 Mn
Mar 31, 2023 393.83 Mn
Mar 31, 2023 32.01 Mn
Mar 31, 2023 393.83 Mn
Mar 31, 2023 32.01 Mn